Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Umai Chemical is a specialized Japanese manufacturer of inorganic chemicals, primarily serving the pharmaceutical and food industries. Founded in 1947 and headquartered in Tokushima, the company is a leading producer of high-purity magnesium and aluminum compounds, including magnesium sulfate and magnesium oxide. As a GMP-certified manufacturer, Umai Chemical provides Active Pharmaceutical Ingredients (APIs) used in applications such as dialysis, antacids, and mineral supplements. The company operates as a Contract Development and Manufacturing Organization (CDMO), leveraging its expertise in inorganic synthesis and purification. Their products are essential components in various medical treatments and nutritional products globally. Umai Chemical maintains a strong reputation for quality control and technical innovation in the inorganic chemical sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on UMAI CHEMICAL.